Tag: INTELLITAB

Latest articles

Man standing at flipboard with graphs and charts on it to show Fewer than half of US clinical trials comply with law on reporting results

Fewer than half of US clinical trials comply with law on reporting results

Research into reporting of US clinical trial results finds that less than half (41%) are reported promptly onto the US trial registry, and one...
Image of blood bag to show study confirms benefits of blood anticoagulants for heart failure patients

Study confirms benefits of blood anticoagulants for heart failure patients

British clinical AI technology company Sensyne Health has announced its part in the results of a study seeking to identify if there are benefits...
graphic of handshake with couple signing a contract in background to depict Bayer and Exscientia collaborate on AI in cardiovascular and oncology drug discovery

Lynparza regulatory submission granted Priority Review in US

AstraZeneca and MSD have announced that a supplemental New Drug Application for Lynparza (olaparib) has been accepted and granted Priority Review in the US...

Popular articles

Image of doctor in a circle with lots of medical icons filtering out in a circular pattern to show mapping the intricate oncology landscape

Mapping the intricate oncology landscape

Simon Grime, of Wilmington Healthcare, explains how data and intelligence tools help pharma deliver tailored engagement programmes to diverse stakeholders in an intricate oncology...
pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
graphic of handshake with couple signing a contract in background to depict Bayer and Exscientia collaborate on AI in cardiovascular and oncology drug discovery

Lynparza regulatory submission granted Priority Review in US

AstraZeneca and MSD have announced that a supplemental New Drug Application for Lynparza (olaparib) has been accepted and granted Priority Review in the US...
Image of blood bag to show study confirms benefits of blood anticoagulants for heart failure patients

Study confirms benefits of blood anticoagulants for heart failure patients

British clinical AI technology company Sensyne Health has announced its part in the results of a study seeking to identify if there are benefits...
moving up the career ladder: Making a career move in pharma

Making a career move in pharma

If you feel that you have gone as far as you can in your current role, it could be time to make a career...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription